US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

iTeos Therapeutics

10.10

-0.0700-0.69%

Post-market: 10.07-0.0300-0.30%17:05 EDT

Volume:883.97K

Turnover:8.95M

Market Cap:386.57M

PE:-3.27

High:10.20

Open:10.10

Low:10.05

Close:10.17

Loading ...

Overview Company News Filings

GSK, iTeos Therapeutics End Belrestotug Development Program

MT Newswires Live

ITeos, GSK discontinue lung cancer therapy development

Iteos Therapeutics Inc - Initiates Review of Strategic Alternatives to Maximize Shareholder Value

THOMSON REUTERS

Iteos Therapeutics Inc - Galaxies Lung-201 Fails to Meet Progression Free Survival Criteria

THOMSON REUTERS

Iteos Reports Topline Interim Results From Galaxies Lung-201 Study of Belrestotug + Dostarlimab in First-Line, Pd-L1 High Non-Small Cell Lung Cancer Patients

THOMSON REUTERS

Iteos Therapeutics Inc - Co and GSK Terminate Belrestotug Development Program

THOMSON REUTERS

Wall Street Analysts See a 211.07% Upside in iTeos Therapeutics (ITOS): Can the Stock Really Move This High?

iTeos Therapeutics Reports Q1 2025 Financial Results

iTeos Therapeutics Is Maintained at Overweight by Wells Fargo

iTeos Therapeutics (ITOS) Receives a Buy from Piper Sandler

iTeos Therapeutics reports Q1 EPS (80c), consensus (90c)

Iteos Therapeutics Inc: Cash Balance and Investment Balance of $624.3 Mln as of March 31, 2025 Expected to Provide Runway Through 2027

THOMSON REUTERS

iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates

Positive week for iTeos Therapeutics, Inc. (NASDAQ:ITOS) institutional investors who lost 38% over the past year

Simply Wall St.

iTeos Therapeutics (ITOS) Gets a Buy from Piper Sandler

iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025

iTeos Therapeutics: Poised for Success with Anti-TIGIT Therapies Amidst Competitive Landscape

iTeos Therapeutics Is Maintained at Overweight by JP Morgan

iTeos Therapeutics price target lowered to $17 from $19 at Wells Fargo

Promising Developments and Strategic Updates Drive Buy Rating for iTeos Therapeutics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ITOS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ITOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ITOS\",,,,,undefined,":{"symbol":"ITOS","market":"US","secType":"STK","nameCN":"iTeos Therapeutics","latestPrice":10.1,"timestamp":1750104000000,"preClose":10.17,"halted":0,"volume":883965,"hourTrading":{"tag":"盘后","latestPrice":10.07,"preClose":10.1,"latestTime":"17:05 EDT","volume":12242,"amount":123649.133526,"timestamp":1750107950718},"delay":0,"floatShares":22095909,"shares":38273795,"eps":-3.090709,"marketStatus":"Post-Mkt","change":-0.07,"latestTime":"06-16 18:13:54 EDT","open":10.1,"high":10.2,"low":10.05,"amount":8947771.295009999,"amplitude":0.014749,"askPrice":10.12,"askSize":800,"bidPrice":10.05,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-3.090709,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750118400000},"marketStatusCode":4,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":10.17,"postHourTrading":{"tag":"盘后","latestPrice":10.07,"preClose":10.1,"latestTime":"17:05 EDT","volume":12242,"amount":123649.133526,"timestamp":1750107950718},"volumeRatio":0.901255,"impliedVol":1.5365,"impliedVolPercentile":0.928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ITOS\",,,,,undefined,":{"symbol":"ITOS","floatShares":22095909,"roa":"-14.54%","roe":"-23.68%","lyrEps":-3.320964,"volumeRatio":0.901255,"shares":38273795,"dividePrice":0,"high":10.2,"amplitude":0.014749,"preClose":10.17,"low":10.05,"week52Low":4.8,"pbRate":"0.69","psRate":"11.04","week52High":18.13,"institutionHeld":0,"latestPrice":10.1,"committee":0.111111,"eps":-3.090709,"divideRate":0,"volume":883965,"delay":0,"ttmEps":-3.090709,"open":10.1,"prevYearClose":7.68,"prevWeekClose":10.17,"prevMonthClose":10.02,"prevQuarterClose":5.97,"fiveDayClose":10.04,"twentyDayClose":7.81,"sixtyDayClose":6.885},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ITOS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535832773","title":"GSK, iTeos Therapeutics End Belrestotug Development Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2535832773","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535832773?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:43","pubTimestamp":1747140182,"startTime":"0","endTime":"0","summary":"GSK  and iTeos Therapeutics  said Tuesday they are ending the development program for belrestotug as two phase 2 cancer studies failed to meet the efficacy criteria for continued development.The companies said that as a result, they are ending their collaboration and all belrestotug-containing study groups.ITeos said the study evaluating the belrestotug plus dostarlimab doublet in previously untreated, unresectable, locally advanced or metastatic PD-L1 high non-small cell lung cancer didn't meet established criteria for clinically meaningful improvements in the secondary endpoint of progression-free survival.The company added that the other trial showed a trend lower than the meaningful threshold for objective response rate in the belrestotug combination groups compared with dostarlimab monotherapy in PD-L1 positive head and neck squamous cell carcinoma.The company said any new enrollment in an ongoing phase 3 trial is ending, adding that GSK is reaching out to various parties about th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4588","BK4139","ITOS","LU1829250122.USD","BK4532","BK4585","GSK.UK","GSK"],"gpt_icon":0},{"id":"2535720886","title":"ITeos, GSK discontinue lung cancer therapy development","url":"https://stock-news.laohu8.com/highlight/detail?id=2535720886","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535720886?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:12","pubTimestamp":1747138346,"startTime":"0","endTime":"0","summary":"ITeos, GSK discontinue lung cancer therapy developmentMay 13  - iTeos Therapeutics ITOS.O and partner GSK GSK.L said on Tuesday that they terminated the development of their experimental lung cancer therapy after its failure to significantly improve progression free survival in a mid-stage trial.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL4N3RL13F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1481599808.USD","LU1228905037.USD","LU1302929846.USD","BK4139","LU1202635105.USD","LU0971552673.USD","BK5011","LU0058720904.USD","LU0545562505.USD","LU0971552830.HKD","LU0985481810.HKD","LU0321505868.SGD","LU0306806265.USD","LU1098665638.USD","LU1228905540.USD","LU1670756490.USD","LU0575583348.USD","LU0225284248.USD","LU0203345920.USD","LU0211331839.USD","LU1487256676.USD","LU1400636574.HKD","LU0321505439.SGD","ITOS","IE00BQJZX424.USD","LU0203347892.USD","IE0034235071.USD","LU1400636491.USD","LU0289739699.SGD","LU0109981661.USD","LU1481600234.SGD","LU1035777561.USD","LU0306807586.USD","LU0225771236.USD","LU1064927863.SGD","LU1645745479.HKD","LU1400636657.SGD","GSK.UK","IE00BWDBJ516.SGD","LU1046248800.SGD","LU1015430645.USD"],"gpt_icon":0},{"id":"2535722445","title":"Iteos Therapeutics Inc - Initiates Review of Strategic Alternatives to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2535722445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535722445?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:55","pubTimestamp":1747137300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUAB3VT6P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ITOS","BK4139"],"gpt_icon":0},{"id":"2535722412","title":"Iteos Therapeutics Inc - Galaxies Lung-201 Fails to Meet Progression Free Survival Criteria","url":"https://stock-news.laohu8.com/highlight/detail?id=2535722412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535722412?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:55","pubTimestamp":1747137300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUAB3VT6P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ITOS","BK4139"],"gpt_icon":0},{"id":"2535224177","title":"Iteos Reports Topline Interim Results From Galaxies Lung-201 Study of Belrestotug + Dostarlimab in First-Line, Pd-L1 High Non-Small Cell Lung Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2535224177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535224177?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:55","pubTimestamp":1747137300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUAB3VT6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ITOS"],"gpt_icon":0},{"id":"2535172241","title":"Iteos Therapeutics Inc - Co and GSK Terminate Belrestotug Development Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2535172241","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535172241?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:55","pubTimestamp":1747137300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUAB3VT6P:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505439.SGD","IE00BQJZX424.USD","LU0203347892.USD","BK4139","LU0289739699.SGD","LU1046248800.SGD","LU0321505868.SGD","LU0971552673.USD","LU1645745479.HKD","LU1670756490.USD","LU0306806265.USD","LU0225771236.USD","LU0575583348.USD","IE0034235071.USD","LU1400636574.HKD","LU1481600234.SGD","IE00BWDBJ516.SGD","LU1302929846.USD","LU0211331839.USD","LU0985481810.HKD","LU0058720904.USD","LU1487256676.USD","LU1481599808.USD","LU1035777561.USD","LU0306807586.USD","ITOS","LU1400636657.SGD","BK5011","LU1064927863.SGD","LU0109981661.USD","LU1015430645.USD","LU0225284248.USD","LU1228905540.USD","LU1228905037.USD","LU0971552830.HKD","LU1400636491.USD","LU0203345920.USD","LU1202635105.USD","GSK.UK","LU1098665638.USD","LU0545562505.USD"],"gpt_icon":0},{"id":"2532784829","title":"Wall Street Analysts See a 211.07% Upside in iTeos Therapeutics (ITOS): Can the Stock Really Move This High?","url":"https://stock-news.laohu8.com/highlight/detail?id=2532784829","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532784829?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:55","pubTimestamp":1746194113,"startTime":"0","endTime":"0","summary":"Shares of iTeos Therapeutics, Inc.  have gained 31.6% over the past four weeks to close the last trading session at $7.50, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $23.33 indicates a potential upside of 211.1%.The average comprises six short-term price targets ranging from a low of $15 to a high of $47, with a standard deviation of $12.21. While the lowest estimate indicates an increase of 100% from the current price level, the most optimistic estimate points to a 526.7% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.That said, while investors should not entirely ignore price targets, making an investment decision solely based","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wall-street-analysts-see-211-135513656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ITOS","BK4139"],"gpt_icon":0},{"id":"2531177818","title":"iTeos Therapeutics Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2531177818","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531177818?lang=en_us&edition=fundamental","pubTime":"2025-04-30 12:48","pubTimestamp":1745988537,"startTime":"0","endTime":"0","summary":"Iteos Therapeutics, Inc. ( ($ITOS) ) has released its Q1 earnings. Here is a breakdown of the information Iteos Therapeutics, Inc. presented to its...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iteos-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iteos-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ITOS","BK4139"],"gpt_icon":0},{"id":"2531946755","title":"iTeos Therapeutics Is Maintained at Overweight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2531946755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531946755?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:13","pubTimestamp":1745935980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ITOS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 29, 2025 10:13 ET (14:13 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITOS"],"gpt_icon":0},{"id":"2531881027","title":"iTeos Therapeutics (ITOS) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2531881027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531881027?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:39","pubTimestamp":1745923198,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on iTeos Therapeutics (ITOS – Research Report) today and set a price target of $16.00...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/iteos-therapeutics-itos-receives-a-buy-from-piper-sandler-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/iteos-therapeutics-itos-receives-a-buy-from-piper-sandler-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ITOS","BK4139"],"gpt_icon":0},{"id":"2531699702","title":"iTeos Therapeutics reports Q1 EPS (80c), consensus (90c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2531699702","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531699702?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:55","pubTimestamp":1745873716,"startTime":"0","endTime":"0","summary":"“The second quarter marks a significant inflection point for iTeos with the next interim assessment from GALAXIES Lung-201, which includes the init...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/iteos-therapeutics-reports-q1-eps-80c-consensus-90c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/iteos-therapeutics-reports-q1-eps-80c-consensus-90c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ITOS"],"gpt_icon":0},{"id":"2531265771","title":"Iteos Therapeutics Inc: Cash Balance and Investment Balance of $624.3 Mln as of March 31, 2025 Expected to Provide Runway Through 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2531265771","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531265771?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:30","pubTimestamp":1745872201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nTUABN2JHB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ITOS"],"gpt_icon":0},{"id":"2531266942","title":"iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2531266942","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531266942?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:30","pubTimestamp":1745872200,"startTime":"0","endTime":"0","summary":"- Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25. - Interim datasets from GALAXIES H&N-202 and TIG-006 HNSCC with ~200 patients anticipated in 2025. - Cash balance and investment balance of $624.3 million as of March 31, 2025 expected to provide runway through 2027. WATERTOWN, Mass. and GOSSELIES, Belgium, April 28, 2025  -- iTeos Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today reported financial results for the first quarter ended March 31, 2025 and provided a business update.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/iteos-reports-first-quarter-2025-203000148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ITOS"],"gpt_icon":0},{"id":"2528058860","title":"Positive week for iTeos Therapeutics, Inc. (NASDAQ:ITOS) institutional investors who lost 38% over the past year","url":"https://stock-news.laohu8.com/highlight/detail?id=2528058860","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528058860?lang=en_us&edition=fundamental","pubTime":"2025-04-19 20:31","pubTimestamp":1745065863,"startTime":"0","endTime":"0","summary":"Given the large stake in the stock by institutions, iTeos Therapeutics' stock price might be vulnerable to their trading decisions. Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company. We check all companies for important risks. See what we found for iTeos Therapeutics in our. If you want to know who really controls iTeos Therapeutics, Inc. , then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions with 64% ownership. Put another way, the group faces the maximum upside potential .Institutional investors would probably welcome last week's 15% increase in the share price after a year of 38% losses as a sign that returns may to begin trending higher.Check out our latest analysis for iTeos Therapeutics. What Does The Institutional Ownership Tell Us About iTeos Therapeutics?Researching institutional ownership is a good way to gauge and filter a st","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/positive-week-iteos-therapeutics-inc-123103551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BGHQF748.EUR","IE00B3QW5Z07.USD","ITOS","LU2095319765.USD","TSYW.SI","BK4588","PSQ","TQQQ","IE00BKPKM429.USD","BK4585","NDAQ","BK4139","MNQmain","NVIW.SI","LU2210150020.SGD","USJW.SI","LU2210149790.SGD","IE00B64PRP62.GBP","USAW.SI","QLD","SQQQ","BK4112","QID","NQmain",".IXIC"],"gpt_icon":1},{"id":"2523917942","title":"iTeos Therapeutics (ITOS) Gets a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2523917942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523917942?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:56","pubTimestamp":1743418604,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Tenthoff from Piper Sandler maintained a Buy rating on iTeos Therapeutics (ITOS – Research Report), with a price...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/iteos-therapeutics-itos-gets-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/iteos-therapeutics-itos-gets-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ITOS"],"gpt_icon":0},{"id":"2522838067","title":"iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522838067","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522838067?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:35","pubTimestamp":1742934900,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass. and GOSSELIES, Belgium, March 25, 2025  -- iTeos Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced the poster presentations of preclinical data on EOS-215, a potential best-in-class antibody targeting TREM2, and a novel small molecule inhibiting PTPN1/2 at the American Association for Cancer Research  Annual Meeting, being held April 25-30, 2025 in Chicago, Illinois.Abstract 3136, “EOS-215, a first-in-class TREM2 antagonist, designed to reprogram the tumor microenvironment and overcome resistance”。Session: Experimental and Molecular Therapeutics - Therapeutic Approaches to Attack the Tumor Microenvironment. Date and Time: Monday, April 28, 2025, 2:30 PM - 5:00 P.M. CDT. This press release contains forward-looking statements. Any statements that are not solely statements of historical fact are forward-loo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/iteos-present-preclinical-data-potential-203500785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AFG","BK4117","ITOS","BK4107"],"gpt_icon":0},{"id":"2517310099","title":"iTeos Therapeutics: Poised for Success with Anti-TIGIT Therapies Amidst Competitive Landscape","url":"https://stock-news.laohu8.com/highlight/detail?id=2517310099","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517310099?lang=en_us&edition=fundamental","pubTime":"2025-03-07 18:36","pubTimestamp":1741343811,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Daina Graybosch maintained a Buy rating on iTeos Therapeutics (ITOS – Research Report) on March 5 and set a price target o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/iteos-therapeutics-poised-for-success-with-anti-tigit-therapies-amidst-competitive-landscape?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/iteos-therapeutics-poised-for-success-with-anti-tigit-therapies-amidst-competitive-landscape?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ITOS","BK4139"],"gpt_icon":0},{"id":"2517167627","title":"iTeos Therapeutics Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167627","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517167627?lang=en_us&edition=fundamental","pubTime":"2025-03-07 00:26","pubTimestamp":1741278360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ITOS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2025 11:26 ET (16:26 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITOS"],"gpt_icon":0},{"id":"2517154467","title":"iTeos Therapeutics price target lowered to $17 from $19 at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154467","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154467?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:50","pubTimestamp":1741265451,"startTime":"0","endTime":"0","summary":"Wells Fargo lowered the firm’s price target on iTeos Therapeutics (ITOS) to $17 from $19 and keeps an Overweight rating on the shares. The firm say...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/iteos-therapeutics-price-target-lowered-to-17-from-19-at-wells-fargo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/iteos-therapeutics-price-target-lowered-to-17-from-19-at-wells-fargo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ITOS"],"gpt_icon":0},{"id":"2517624155","title":"Promising Developments and Strategic Updates Drive Buy Rating for iTeos Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2517624155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517624155?lang=en_us&edition=fundamental","pubTime":"2025-03-06 19:37","pubTimestamp":1741261040,"startTime":"0","endTime":"0","summary":"Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on iTeos Therapeutics (ITOS – Research Report) and keeping the price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-and-strategic-updates-drive-buy-rating-for-iteos-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-and-strategic-updates-drive-buy-rating-for-iteos-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ITOS"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":80,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ITOS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-28","symbol":"ITOS","fiscalQuarterEnding":"2025/03","expectedEps":-0.94,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745812800000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2025-03-05","symbol":"ITOS","fiscalQuarterEnding":"2024/12","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"pre","actualEps":-1.01},{"market":"US","date":"2024-11-12","symbol":"ITOS","fiscalQuarterEnding":"2024/09","expectedEps":-1.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.05},{"market":"US","date":"2024-08-08","symbol":"ITOS","fiscalQuarterEnding":"2024/06","expectedEps":-1.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2024-05-10","symbol":"ITOS","fiscalQuarterEnding":"2024/03","expectedEps":-1.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":-1.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ITOS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ITOS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.1667,"hold":0.8333,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.8333,"analysts":6,"updateTime":1748664000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ITOS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ITOS","date":"2025-06-13","current":-2.920033,"percent":0.526578,"low":-54.340582,"twenty":-18.238576,"median":-3.271041,"eighty":2.961744,"high":114.493626,"avg":-0.164892,"sd":31.359868,"marketCap":381972474},"quantilePoints":[{"date":"2020-07-24","current":-27.337357,"twenty":-26.75859,"median":-25.890439,"eighty":-25.890439,"marketCap":636933073},{"date":"2020-07-31","current":-28.241427,"twenty":-27.176633,"median":-26.332835,"eighty":-25.890439,"marketCap":657997001},{"date":"2020-08-07","current":-40.051739,"twenty":-38.174717,"median":-27.337357,"eighty":-25.981295,"marketCap":933165463},{"date":"2020-08-14","current":-45.06,"twenty":-42.155496,"median":-34.440765,"eighty":-26.289784,"marketCap":1049852939},{"date":"2020-08-21","current":-42.878752,"twenty":-43.808652,"median":-40.611401,"eighty":-26.703073,"marketCap":999032033},{"date":"2020-08-28","current":-42.491293,"twenty":-43.231769,"median":-41.163888,"eighty":-27.096272,"marketCap":990004635},{"date":"2020-09-04","current":-36.53741,"twenty":-43.128447,"median":-40.884057,"eighty":-27.698985,"marketCap":904154756},{"date":"2020-09-11","current":-42.018022,"twenty":-43.016514,"median":-40.884057,"eighty":-29.29761,"marketCap":1039777969},{"date":"2020-09-18","current":-40.120342,"twenty":-42.86805,"median":-41.005454,"eighty":-33.889712,"marketCap":992817994},{"date":"2020-09-25","current":-34.243201,"twenty":-42.784284,"median":-40.611401,"eighty":-33.373946,"marketCap":847382248},{"date":"2020-10-02","current":-32.642919,"twenty":-42.594615,"median":-39.901938,"eighty":-33.373946,"marketCap":807781671},{"date":"2020-10-09","current":-32.57211,"twenty":-42.402321,"median":-39.143179,"eighty":-31.427838,"marketCap":806029434},{"date":"2020-10-16","current":-31.750726,"twenty":-42.040751,"median":-38.123531,"eighty":-31.818703,"marketCap":785703474},{"date":"2020-10-23","current":-34.413142,"twenty":-42.01519,"median":-36.225851,"eighty":-31.818703,"marketCap":851587619},{"date":"2020-10-30","current":-32.246389,"twenty":-41.926273,"median":-34.816753,"eighty":-31.818703,"marketCap":797969139},{"date":"2020-11-06","current":-36.041748,"twenty":-41.584353,"median":-34.965452,"eighty":-32.099106,"marketCap":891889091},{"date":"2020-11-13","current":-28.719367,"twenty":-41.4552,"median":-34.95129,"eighty":-31.818703,"marketCap":818645546},{"date":"2020-11-20","current":-31.227394,"twenty":-41.371645,"median":-34.696378,"eighty":-31.116278,"marketCap":890136853},{"date":"2020-11-27","current":-35.124671,"twenty":-41.083344,"median":-34.696378,"eighty":-31.184255,"marketCap":1001228736},{"date":"2020-12-04","current":-36.169682,"twenty":-41.083344,"median":-34.618488,"eighty":-31.227394,"marketCap":1031016780},{"date":"2020-12-11","current":-35.100082,"twenty":-41.040859,"median":-34.696378,"eighty":-31.637432,"marketCap":1000527840},{"date":"2020-12-18","current":-40.718554,"twenty":-40.97005,"median":-34.995885,"eighty":-31.750726,"marketCap":1160682384},{"date":"2020-12-24","current":-40.989028,"twenty":-40.999394,"median":-35.112376,"eighty":-32.022632,"marketCap":1168392231},{"date":"2020-12-31","current":-41.579152,"twenty":-41.057853,"median":-35.311017,"eighty":-32.103791,"marketCap":1185213715},{"date":"2021-01-08","current":-40.571023,"twenty":-41.00976,"median":-36.009857,"eighty":-32.124889,"marketCap":1156477014},{"date":"2021-01-15","current":-43.189698,"twenty":-41.00976,"median":-36.119877,"eighty":-32.17558,"marketCap":1231122348},{"date":"2021-01-22","current":-40.263667,"twenty":-41.083344,"median":-36.211689,"eighty":-32.220897,"marketCap":1147715824},{"date":"2021-01-29","current":-39.341598,"twenty":-41.06635,"median":-36.575392,"eighty":-32.303036,"marketCap":1121432256},{"date":"2021-02-05","current":-47.025504,"twenty":-41.144779,"median":-37.222471,"eighty":-32.393672,"marketCap":1340461993},{"date":"2021-02-12","current":-44.259298,"twenty":-41.601215,"median":-38.265148,"eighty":-32.458816,"marketCap":1261611288},{"date":"2021-02-19","current":-49.70565,"twenty":-41.788154,"median":-38.579355,"eighty":-32.549451,"marketCap":1416859565},{"date":"2021-02-26","current":-51.119489,"twenty":-42.402321,"median":-38.978918,"eighty":-32.57211,"marketCap":1457161037},{"date":"2021-03-05","current":-42.58728,"twenty":-42.86805,"median":-39.143179,"eighty":-32.583476,"marketCap":1213950417},{"date":"2021-03-12","current":-48.119692,"twenty":-43.18778,"median":-39.482982,"eighty":-32.631734,"marketCap":1371651828},{"date":"2021-03-19","current":-48.623756,"twenty":-43.250908,"median":-39.667165,"eighty":-32.701594,"marketCap":1386020178},{"date":"2021-03-26","current":-30.980291,"twenty":-43.989466,"median":-39.645765,"eighty":-32.583476,"marketCap":1178273396},{"date":"2021-04-01","current":-32.586061,"twenty":-43.26621,"median":-39.482982,"eighty":-32.543786,"marketCap":1239345654},{"date":"2021-04-09","current":-24.926352,"twenty":-43.189698,"median":-39.143179,"eighty":-32.246389,"marketCap":948023962},{"date":"2021-04-16","current":-20.57047,"twenty":-43.180108,"median":-38.978918,"eighty":-32.090609,"marketCap":782356687},{"date":"2021-04-23","current":-22.000898,"twenty":-43.050955,"median":-38.579355,"eighty":-31.543233,"marketCap":836760136},{"date":"2021-04-30","current":-21.696355,"twenty":-42.968402,"median":-38.123531,"eighty":-30.980291,"marketCap":825177466},{"date":"2021-05-07","current":-21.319198,"twenty":-42.878752,"median":-37.128633,"eighty":-30.329913,"marketCap":810833076},{"date":"2021-05-14","current":-18.550787,"twenty":-42.833165,"median":-36.556401,"eighty":-29.614463,"marketCap":859272455},{"date":"2021-05-21","current":-16.921531,"twenty":-42.825244,"median":-36.197527,"eighty":-28.553178,"marketCap":783805307},{"date":"2021-05-28","current":-15.56508,"twenty":-42.620446,"median":-36.055909,"eighty":-27.685693,"marketCap":720974519},{"date":"2021-06-04","current":-13.564505,"twenty":-42.593913,"median":-35.911503,"eighty":-26.461987,"marketCap":628307882},{"date":"2021-06-11","current":-15.178606,"twenty":-42.51049,"median":-35.26285,"eighty":-25.156078,"marketCap":703073009},{"date":"2021-06-18","current":-18.997885,"twenty":-42.135405,"median":-35.063199,"eighty":-22.392189,"marketCap":879982044},{"date":"2021-06-25","current":-19.293425,"twenty":-42.023704,"median":-34.937128,"eighty":-22.110803,"marketCap":893671434},{"date":"2021-07-02","current":-19.149444,"twenty":-42.006692,"median":-34.646198,"eighty":-21.807097,"marketCap":887002244},{"date":"2021-07-09","current":-19.60412,"twenty":-41.985085,"median":-34.47687,"eighty":-21.517806,"marketCap":908062844},{"date":"2021-07-16","current":-18.323449,"twenty":-41.891426,"median":-34.243201,"eighty":-20.844839,"marketCap":848742155},{"date":"2021-07-23","current":-18.42954,"twenty":-41.815201,"median":-33.564132,"eighty":-20.566778,"marketCap":853656295},{"date":"2021-07-30","current":-18.20978,"twenty":-41.763565,"median":-33.336846,"eighty":-19.692024,"marketCap":843477005},{"date":"2021-08-06","current":-18.952418,"twenty":-41.716847,"median":-33.286513,"eighty":-19.42182,"marketCap":877875984},{"date":"2021-08-13","current":-13.229766,"twenty":-41.650392,"median":-33.096119,"eighty":-19.207036,"marketCap":867568363},{"date":"2021-08-20","current":-13.96535,"twenty":-41.593861,"median":-32.635928,"eighty":-19.055478,"marketCap":915805727},{"date":"2021-08-27","current":-15.028456,"twenty":-41.506503,"median":-32.57211,"eighty":-18.970605,"marketCap":985521042},{"date":"2021-09-03","current":-15.468732,"twenty":-41.44946,"median":-32.472977,"eighty":-18.896341,"marketCap":1014393041},{"date":"2021-09-10","current":-14.786841,"twenty":-41.340526,"median":-32.317198,"eighty":-18.68719,"marketCap":969676652},{"date":"2021-09-17","current":-15.436517,"twenty":-41.144779,"median":-32.133095,"eighty":-18.528053,"marketCap":1012280456},{"date":"2021-09-24","current":-14.743887,"twenty":-41.083344,"median":-31.983035,"eighty":-18.347698,"marketCap":966859872},{"date":"2021-10-01","current":-14.502272,"twenty":-41.06635,"median":-31.637432,"eighty":-18.215842,"marketCap":951015482},{"date":"2021-10-08","current":-14.464687,"twenty":-41.020127,"median":-31.205824,"eighty":-17.74601,"marketCap":948550799},{"date":"2021-10-15","current":-15.012348,"twenty":-40.981437,"median":-30.980291,"eighty":-16.930625,"marketCap":984464749},{"date":"2021-10-22","current":-14.700933,"twenty":-40.935653,"median":-30.575298,"eighty":-15.846503,"marketCap":964043091},{"date":"2021-10-29","current":-14.362672,"twenty":-40.867033,"median":-29.936497,"eighty":-15.593119,"marketCap":941860946},{"date":"2021-11-05","current":-15.903639,"twenty":-40.836579,"median":-29.725206,"eighty":-15.507271,"marketCap":1042912943},{"date":"2021-11-12","current":72.270214,"twenty":-40.829202,"median":-29.444727,"eighty":-15.423631,"marketCap":1065624307},{"date":"2021-11-19","current":91.432227,"twenty":-40.819367,"median":-28.531771,"eighty":-15.345272,"marketCap":1348168190},{"date":"2021-11-26","current":84.064062,"twenty":-40.787402,"median":-28.360388,"eighty":-15.187234,"marketCap":1239524600},{"date":"2021-12-03","current":83.298539,"twenty":-40.716095,"median":-27.337357,"eighty":-15.056376,"marketCap":1228236954},{"date":"2021-12-10","current":84.781741,"twenty":-40.70626,"median":-26.332835,"eighty":-14.987733,"marketCap":1250106767},{"date":"2021-12-17","current":103.345689,"twenty":-40.701342,"median":-25.890439,"eighty":-14.837312,"marketCap":1523832177},{"date":"2021-12-23","current":112.244901,"twenty":-40.681671,"median":-24.926352,"eighty":-14.786841,"marketCap":1655051059},{"date":"2021-12-31","current":111.383687,"twenty":-40.644789,"median":-22.518342,"eighty":-14.743887,"marketCap":1642352458},{"date":"2022-01-07","current":102.891159,"twenty":-40.611401,"median":-22.250069,"eighty":-14.684825,"marketCap":1517130137},{"date":"2022-01-14","current":94.877083,"twenty":-40.571023,"median":-22.093813,"eighty":-14.572072,"marketCap":1398962596},{"date":"2022-01-21","current":86.336711,"twenty":-40.551353,"median":-21.95014,"eighty":-14.501198,"marketCap":1273034798},{"date":"2022-01-28","current":83.107158,"twenty":-40.467752,"median":-21.696355,"eighty":-14.450353,"marketCap":1225415042},{"date":"2022-02-04","current":86.408478,"twenty":-40.418575,"median":-21.484705,"eighty":-14.357303,"marketCap":1274093015},{"date":"2022-02-11","current":83.992295,"twenty":-40.293173,"median":-21.253384,"eighty":-14.22541,"marketCap":1238466383},{"date":"2022-02-18","current":80.9302,"twenty":-40.149007,"median":-20.830076,"eighty":-14.059848,"marketCap":1193315800},{"date":"2022-02-25","current":85.858258,"twenty":-40.07918,"median":-20.580285,"eighty":-13.512221,"marketCap":1265980019},{"date":"2022-03-04","current":80.547438,"twenty":-40.023988,"median":-20.066374,"eighty":-13.268425,"marketCap":1187671977},{"date":"2022-03-11","current":85.78649,"twenty":-40.005488,"median":-19.683688,"eighty":70.691322,"marketCap":1264921802},{"date":"2022-03-18","current":88.513668,"twenty":-39.853477,"median":-19.528341,"eighty":76.935124,"marketCap":1305134041},{"date":"2022-03-25","current":5.511262,"twenty":-39.701153,"median":-19.349722,"eighty":77.643233,"marketCap":1182281466},{"date":"2022-04-01","current":5.228166,"twenty":-39.641486,"median":-19.225223,"eighty":76.935124,"marketCap":1121551478},{"date":"2022-04-08","current":5.810913,"twenty":-39.565354,"median":-19.149444,"eighty":74.408896,"marketCap":1246562916},{"date":"2022-04-14","current":5.406964,"twenty":-39.491588,"median":-19.05472,"eighty":72.542932,"marketCap":1159907260},{"date":"2022-04-22","current":4.83415,"twenty":-39.40061,"median":-18.997885,"eighty":71.8109,"marketCap":1037026699},{"date":"2022-04-29","current":4.419796,"twenty":-39.26223,"median":-18.952418,"eighty":70.834857,"marketCap":948139163},{"date":"2022-05-06","current":4.18796,"twenty":-39.110534,"median":-18.899372,"eighty":44.566915,"marketCap":898405374},{"date":"2022-05-13","current":2.21863,"twenty":-39.060472,"median":-18.747813,"eighty":5.774491,"marketCap":660346280},{"date":"2022-05-20","current":2.219824,"twenty":-38.9949,"median":-18.6493,"eighty":5.718535,"marketCap":660701687},{"date":"2022-05-27","current":2.040709,"twenty":-38.849828,"median":-18.531842,"eighty":5.714561,"marketCap":607390631},{"date":"2022-06-03","current":2.266393,"twenty":-38.736721,"median":-18.46743,"eighty":5.701979,"marketCap":674562561},{"date":"2022-06-10","current":2.11952,"twenty":-38.542472,"median":-18.323449,"eighty":5.655624,"marketCap":630847496},{"date":"2022-06-17","current":2.222212,"twenty":-38.368982,"median":-18.259037,"eighty":5.61854,"marketCap":661412501},{"date":"2022-06-24","current":2.455061,"twenty":-38.265148,"median":-18.164313,"eighty":5.59735,"marketCap":730716874},{"date":"2022-07-01","current":2.492078,"twenty":-37.981913,"median":-18.005176,"eighty":5.546028,"marketCap":741734492},{"date":"2022-07-08","current":2.791796,"twenty":-37.44943,"median":-17.25496,"eighty":5.518215,"marketCap":830941659},{"date":"2022-07-15","current":2.925534,"twenty":-37.166168,"median":-16.932898,"eighty":5.496693,"marketCap":870747248},{"date":"2022-07-22","current":2.935087,"twenty":-36.68604,"median":-16.466855,"eighty":5.471861,"marketCap":873590504},{"date":"2022-07-29","current":2.920758,"twenty":-36.575392,"median":-15.860685,"eighty":5.418884,"marketCap":869325619},{"date":"2022-08-05","current":3.253911,"twenty":-36.545006,"median":-15.812362,"eighty":5.353986,"marketCap":968484184},{"date":"2022-08-12","current":2.736215,"twenty":-36.288163,"median":-15.734509,"eighty":5.330147,"marketCap":902190191},{"date":"2022-08-19","current":2.475109,"twenty":-36.203192,"median":-15.635178,"eighty":5.30101,"marketCap":816097909},{"date":"2022-08-26","current":2.460004,"twenty":-36.175251,"median":-15.452624,"eighty":5.286441,"marketCap":811117364},{"date":"2022-09-02","current":2.449214,"twenty":-36.089993,"median":-15.355978,"eighty":5.239424,"marketCap":807559832},{"date":"2022-09-09","current":2.380162,"twenty":-36.053077,"median":-15.34532,"eighty":5.227173,"marketCap":784791625},{"date":"2022-09-16","current":2.169766,"twenty":-36.022613,"median":-15.267387,"eighty":5.200685,"marketCap":715419745},{"date":"2022-09-23","current":2.059714,"twenty":-35.891832,"median":-15.141209,"eighty":5.157641,"marketCap":679132916},{"date":"2022-09-30","current":2.055398,"twenty":-35.540771,"median":-15.06604,"eighty":5.036125,"marketCap":677709903},{"date":"2022-10-07","current":1.968003,"twenty":-35.301384,"median":-15.028456,"eighty":4.959443,"marketCap":648893891},{"date":"2022-10-14","current":1.944266,"twenty":-35.179943,"median":-14.970118,"eighty":4.88236,"marketCap":641067320},{"date":"2022-10-21","current":2.054319,"twenty":-35.109918,"median":-14.845902,"eighty":4.729608,"marketCap":677354149},{"date":"2022-10-28","current":2.19674,"twenty":-35.055823,"median":-14.819056,"eighty":4.646003,"marketCap":724313576},{"date":"2022-11-04","current":2.019793,"twenty":-34.989798,"median":-14.776102,"eighty":4.629774,"marketCap":665970046},{"date":"2022-11-11","current":2.928375,"twenty":-34.948458,"median":-14.745275,"eighty":4.619176,"marketCap":764513691},{"date":"2022-11-18","current":2.852065,"twenty":-34.792678,"median":-14.711672,"eighty":4.614208,"marketCap":744591510},{"date":"2022-11-25","current":2.715798,"twenty":-34.696378,"median":-14.684825,"eighty":4.604935,"marketCap":709016187},{"date":"2022-12-02","current":2.729425,"twenty":-34.656234,"median":-14.623079,"eighty":4.523129,"marketCap":712573719},{"date":"2022-12-09","current":2.68582,"twenty":-34.57385,"median":-14.507641,"eighty":4.378728,"marketCap":701189616},{"date":"2022-12-16","current":2.883407,"twenty":-34.489616,"median":-14.499588,"eighty":4.287981,"marketCap":752773834},{"date":"2022-12-23","current":2.563179,"twenty":-34.36216,"median":-14.464687,"eighty":4.221742,"marketCap":669171825},{"date":"2022-12-30","current":2.661292,"twenty":-34.277189,"median":-14.435968,"eighty":4.123708,"marketCap":694786058},{"date":"2023-01-06","current":2.482782,"twenty":-34.243201,"median":-14.394887,"eighty":3.866701,"marketCap":648182385},{"date":"2023-01-13","current":2.598609,"twenty":-33.988289,"median":-14.327772,"eighty":3.253911,"marketCap":678421409},{"date":"2023-01-20","current":2.956991,"twenty":-33.682394,"median":-14.272856,"eighty":3.246269,"marketCap":771984509},{"date":"2023-01-27","current":2.877956,"twenty":-33.539059,"median":-14.190857,"eighty":3.232895,"marketCap":751350821},{"date":"2023-02-03","current":2.830262,"twenty":-33.407934,"median":-14.024411,"eighty":3.226207,"marketCap":738899458},{"date":"2023-02-10","current":2.775756,"twenty":-33.345343,"median":-13.564505,"eighty":3.158383,"marketCap":724669329},{"date":"2023-02-17","current":2.553641,"twenty":-33.319463,"median":-13.374735,"eighty":3.137844,"marketCap":666681553},{"date":"2023-02-24","current":2.402385,"twenty":-33.301743,"median":-13.261982,"eighty":3.129008,"marketCap":627192944},{"date":"2023-03-03","current":2.357417,"twenty":-33.28525,"median":-13.084797,"eighty":3.110858,"marketCap":615453087},{"date":"2023-03-10","current":2.191171,"twenty":-33.271702,"median":1.938871,"eighty":3.090318,"marketCap":572051193},{"date":"2023-03-17","current":5.218434,"twenty":-33.164087,"median":1.956135,"eighty":3.129008,"marketCap":504372062},{"date":"2023-03-24","current":5.037341,"twenty":-33.000224,"median":1.979783,"eighty":3.235761,"marketCap":486869065},{"date":"2023-03-31","current":5.029949,"twenty":-32.760269,"median":1.993898,"eighty":4.210481,"marketCap":486154657},{"date":"2023-04-06","current":4.893206,"twenty":-32.637327,"median":2.005766,"eighty":4.523129,"marketCap":472938109},{"date":"2023-04-14","current":5.144518,"twenty":-32.611787,"median":2.013707,"eighty":4.632092,"marketCap":497227981},{"date":"2023-04-21","current":5.05582,"twenty":-32.580481,"median":2.019793,"eighty":4.82525,"marketCap":488655085},{"date":"2023-04-28","current":4.987904,"twenty":-32.57211,"median":2.029984,"eighty":4.885814,"marketCap":482090915},{"date":"2023-05-05","current":5.202517,"twenty":-32.56078,"median":2.040709,"eighty":4.961094,"marketCap":502833699},{"date":"2023-05-12","current":43.683595,"twenty":-32.487139,"median":2.051082,"eighty":4.979687,"marketCap":503191333},{"date":"2023-05-19","current":45.608939,"twenty":-32.396504,"median":2.056477,"eighty":5.029949,"marketCap":525369369},{"date":"2023-05-26","current":43.12513,"twenty":-32.33136,"median":2.060793,"eighty":5.052863,"marketCap":496758376},{"date":"2023-06-02","current":49.210462,"twenty":-32.237892,"median":2.062037,"eighty":5.085131,"marketCap":566855310},{"date":"2023-06-09","current":46.912939,"twenty":-32.189741,"median":2.065785,"eighty":5.147475,"marketCap":540390141},{"date":"2023-06-16","current":44.087606,"twenty":-32.128992,"median":2.081292,"eighty":5.163736,"marketCap":507845136},{"date":"2023-06-23","current":42.193702,"twenty":-32.112579,"median":2.089796,"eighty":5.202517,"marketCap":486029253},{"date":"2023-06-30","current":41.231226,"twenty":-32.095003,"median":2.095788,"eighty":5.220049,"marketCap":474942493},{"date":"2023-07-07","current":39.647798,"twenty":-31.96152,"median":2.101793,"eighty":5.257281,"marketCap":456702985},{"date":"2023-07-13","current":44.180749,"twenty":-31.825567,"median":2.112814,"eighty":5.314254,"marketCap":508918048},{"date":"2023-07-21","current":43.466654,"twenty":-31.705408,"median":2.138625,"eighty":5.437981,"marketCap":500692388},{"date":"2023-07-28","current":41.883226,"twenty":-31.599752,"median":2.168148,"eighty":5.532122,"marketCap":482452879},{"date":"2023-08-04","current":41.790083,"twenty":-31.416897,"median":2.181632,"eighty":5.692377,"marketCap":481379967},{"date":"2023-08-11","current":-15.266549,"twenty":-31.210138,"median":2.174621,"eighty":5.692377,"marketCap":433676858},{"date":"2023-08-18","current":-14.787895,"twenty":-31.150267,"median":2.141013,"eighty":5.647678,"marketCap":420079729},{"date":"2023-08-25","current":-17.33232,"twenty":-31.051687,"median":2.128459,"eighty":5.613243,"marketCap":492359205},{"date":"2023-09-01","current":-15.19727,"twenty":-30.954247,"median":2.101793,"eighty":5.576821,"marketCap":431708852},{"date":"2023-09-08","current":-15.782992,"twenty":-30.847204,"median":2.100714,"eighty":5.539075,"marketCap":448347445},{"date":"2023-09-15","current":-15.455491,"twenty":-30.575298,"median":2.089796,"eighty":5.50762,"marketCap":439044146},{"date":"2023-09-22","current":-15.203568,"twenty":-30.526221,"median":2.076977,"eighty":5.487753,"marketCap":431887762},{"date":"2023-09-29","current":-14.120298,"twenty":-30.25123,"median":2.064368,"eighty":5.464982,"marketCap":401115311},{"date":"2023-10-06","current":-13.238567,"twenty":-29.936497,"median":2.062037,"eighty":5.458659,"marketCap":376067968},{"date":"2023-10-13","current":-10.801209,"twenty":-29.872863,"median":2.059714,"eighty":5.406964,"marketCap":306829955},{"date":"2023-10-20","current":-11.084623,"twenty":-29.835949,"median":2.055937,"eighty":5.369961,"marketCap":314880887},{"date":"2023-10-27","current":-11.525489,"twenty":-29.747355,"median":2.054858,"eighty":5.358273,"marketCap":327404558},{"date":"2023-11-03","current":-12.142701,"twenty":-29.580993,"median":2.045687,"eighty":5.335444,"marketCap":344937699},{"date":"2023-11-10","current":-5.457325,"twenty":-29.496363,"median":2.038135,"eighty":5.314254,"marketCap":336378605},{"date":"2023-11-17","current":-5.683746,"twenty":-29.154583,"median":2.02041,"eighty":5.290414,"marketCap":350334738},{"date":"2023-11-24","current":-5.660523,"twenty":-28.686129,"median":2.018714,"eighty":5.282128,"marketCap":348903340},{"date":"2023-12-01","current":-5.434102,"twenty":-28.544615,"median":2.008851,"eighty":5.267642,"marketCap":334947206},{"date":"2023-12-08","current":-5.753414,"twenty":-28.504161,"median":1.996056,"eighty":5.243169,"marketCap":354628933},{"date":"2023-12-15","current":-6.252701,"twenty":-28.431765,"median":1.984726,"eighty":5.227835,"marketCap":385403997},{"date":"2023-12-22","current":-6.049503,"twenty":-28.13028,"median":1.968003,"eighty":5.224896,"marketCap":372879262},{"date":"2023-12-29","current":-6.409454,"twenty":-27.79684,"median":1.95128,"eighty":5.220049,"marketCap":395065936},{"date":"2024-01-05","current":-6.496539,"twenty":-27.546359,"median":1.944266,"eighty":5.216508,"marketCap":400433680},{"date":"2024-01-12","current":-6.299147,"twenty":-27.176633,"median":-1.715068,"eighty":5.210658,"marketCap":388266794},{"date":"2024-01-19","current":-6.270118,"twenty":-26.858056,"median":-5.445714,"eighty":5.205477,"marketCap":386477546},{"date":"2024-01-26","current":-6.043697,"twenty":-26.461987,"median":-5.550216,"eighty":5.198707,"marketCap":372521412},{"date":"2024-02-02","current":-5.927584,"twenty":-26.072152,"median":-5.646009,"eighty":5.180851,"marketCap":365364421},{"date":"2024-02-09","current":-6.177228,"twenty":-25.890439,"median":-5.666329,"eighty":5.16965,"marketCap":380751953},{"date":"2024-02-16","current":-5.846305,"twenty":-25.755053,"median":-5.712774,"eighty":5.163736,"marketCap":360354527},{"date":"2024-02-23","current":-5.753414,"twenty":-25.21351,"median":-5.741803,"eighty":5.15191,"marketCap":354628933},{"date":"2024-03-01","current":-6.217867,"twenty":-24.926352,"median":-5.753414,"eighty":5.15191,"marketCap":383256900},{"date":"2024-03-08","current":-3.684802,"twenty":-23.034497,"median":-5.750511,"eighty":5.15191,"marketCap":415063456},{"date":"2024-03-15","current":-3.414329,"twenty":-22.638958,"median":-5.741803,"eighty":5.148214,"marketCap":384596795},{"date":"2024-03-22","current":-3.627525,"twenty":-22.397726,"median":-5.69826,"eighty":5.144518,"marketCap":408611693},{"date":"2024-03-28","current":-4.190746,"twenty":-22.375577,"median":-5.663426,"eighty":5.141242,"marketCap":472054035},{"date":"2024-04-05","current":-3.958457,"twenty":-22.274063,"median":-5.631495,"eighty":5.130895,"marketCap":445888549},{"date":"2024-04-12","current":-3.913909,"twenty":-22.161475,"median":-5.518285,"eighty":5.094011,"marketCap":440870511},{"date":"2024-04-19","current":-3.287047,"twenty":-22.125568,"median":-5.434102,"eighty":5.084365,"marketCap":370259543},{"date":"2024-04-26","current":-3.384479,"twenty":-22.076823,"median":-4.292572,"eighty":5.076261,"marketCap":381234533},{"date":"2024-05-03","current":-3.668648,"twenty":-22.013818,"median":-4.174836,"eighty":5.059516,"marketCap":413243847},{"date":"2024-05-10","current":-3.892151,"twenty":-21.919686,"median":-3.993838,"eighty":5.049906,"marketCap":438419713},{"date":"2024-05-17","current":-4.929955,"twenty":-21.847703,"median":-4.174836,"eighty":5.039558,"marketCap":667057444},{"date":"2024-05-24","current":-4.830805,"twenty":-21.724041,"median":-4.292572,"eighty":5.033314,"marketCap":653641763},{"date":"2024-05-31","current":-4.723393,"twenty":-21.679743,"median":-4.646276,"eighty":5.030892,"marketCap":639108109},{"date":"2024-06-07","current":-4.626997,"twenty":-21.657595,"median":-4.629751,"eighty":5.029949,"marketCap":626065087},{"date":"2024-06-14","current":-4.489289,"twenty":-21.517806,"median":-4.610472,"eighty":5.022557,"marketCap":607432197},{"date":"2024-06-21","current":-4.059639,"twenty":-21.309727,"median":-4.599455,"eighty":5.006757,"marketCap":549297582},{"date":"2024-06-28","current":-4.268956,"twenty":-21.290784,"median":-4.566405,"eighty":4.99733,"marketCap":577619574},{"date":"2024-07-05","current":-4.070656,"twenty":-21.264458,"median":-4.53611,"eighty":4.986982,"marketCap":550788213},{"date":"2024-07-12","current":-4.464501,"twenty":-21.091436,"median":-4.467256,"eighty":4.979687,"marketCap":604078277},{"date":"2024-07-15","current":-4.45073,"twenty":-21.010463,"median":-4.464501,"eighty":4.97673,"marketCap":602214988},{"date":"2024-08-02","current":-4.808772,"twenty":-20.929489,"median":-4.467256,"eighty":4.973774,"marketCap":650660501},{"date":"2024-08-09","current":-5.057702,"twenty":-20.841162,"median":-4.464501,"eighty":4.970817,"marketCap":546914628},{"date":"2024-08-16","current":-5.20462,"twenty":-20.824527,"median":-4.5127,"eighty":4.967438,"marketCap":562801631},{"date":"2024-08-23","current":-5.900371,"twenty":-20.636246,"median":-4.563651,"eighty":4.962921,"marketCap":638036632},{"date":"2024-08-30","current":-5.694348,"twenty":-20.574396,"median":-4.602209,"eighty":4.960185,"marketCap":615758306},{"date":"2024-09-06","current":-5.235017,"twenty":-20.564933,"median":-4.618735,"eighty":4.956698,"marketCap":566088597},{"date":"2024-09-13","current":-5.707858,"twenty":-20.264321,"median":-4.676572,"eighty":4.953273,"marketCap":617219180},{"date":"2024-09-20","current":-3.789477,"twenty":-20.03,"median":-4.628374,"eighty":4.916859,"marketCap":409775100},{"date":"2024-09-27","current":-3.433158,"twenty":-19.837521,"median":-4.604964,"eighty":4.882119,"marketCap":371244554},{"date":"2024-10-04","current":-3.271041,"twenty":-19.675353,"median":-4.565028,"eighty":4.872509,"marketCap":353714068},{"date":"2024-10-11","current":-3.063329,"twenty":-19.619276,"median":-4.53611,"eighty":4.862161,"marketCap":331253134},{"date":"2024-10-18","current":-3.245711,"twenty":-19.558653,"median":-4.467256,"eighty":4.842989,"marketCap":350974930},{"date":"2024-10-25","current":-2.90459,"twenty":-19.47378,"median":-4.343318,"eighty":4.820799,"marketCap":314087867},{"date":"2024-10-31","current":-2.901213,"twenty":-19.42182,"median":-4.299251,"eighty":4.798594,"marketCap":313722648},{"date":"2024-11-08","current":-3.100481,"twenty":-19.359466,"median":-4.222471,"eighty":4.731147,"marketCap":335270537},{"date":"2024-11-15","current":-2.549025,"twenty":-19.297972,"median":-4.191839,"eighty":4.650639,"marketCap":309076946},{"date":"2024-11-22","current":-2.449595,"twenty":-19.266144,"median":-4.16819,"eighty":4.632092,"marketCap":297020753},{"date":"2024-11-29","current":-2.576142,"twenty":-19.21613,"median":-4.125739,"eighty":4.62315,"marketCap":312364998},{"date":"2024-12-06","current":-2.407413,"twenty":-19.173694,"median":-4.087181,"eighty":4.614871,"marketCap":291906004},{"date":"2024-12-13","current":-2.393854,"twenty":-19.149444,"median":-4.070656,"eighty":4.60924,"marketCap":290261978},{"date":"2024-12-20","current":-2.175409,"twenty":-19.131257,"median":-4.037606,"eighty":4.557574,"marketCap":263774887},{"date":"2024-12-27","current":-2.23115,"twenty":-19.058509,"median":-4.02528,"eighty":4.419796,"marketCap":270533662},{"date":"2025-01-03","current":-2.380295,"twenty":-19.052447,"median":-3.958457,"eighty":4.33766,"marketCap":288617952},{"date":"2025-01-10","current":-2.353178,"twenty":-19.02365,"median":-3.933001,"eighty":4.273408,"marketCap":285329899},{"date":"2025-01-17","current":-2.332087,"twenty":-19.000916,"median":-3.922131,"eighty":4.210481,"marketCap":282772525},{"date":"2025-01-24","current":-2.310996,"twenty":-18.991823,"median":-3.904627,"eighty":4.059456,"marketCap":280215151},{"date":"2025-01-31","current":-2.314009,"twenty":-18.970605,"median":-3.892151,"eighty":3.621585,"marketCap":280580490},{"date":"2025-02-07","current":-2.344139,"twenty":-18.952418,"median":-3.831474,"eighty":3.25009,"marketCap":284233882},{"date":"2025-02-14","current":-2.190474,"twenty":-18.946356,"median":-3.789477,"eighty":3.238626,"marketCap":265601583},{"date":"2025-02-21","current":-2.253748,"twenty":-18.929684,"median":-3.761242,"eighty":3.229074,"marketCap":273273706},{"date":"2025-02-28","current":-2.109122,"twenty":-18.897856,"median":-3.726139,"eighty":3.208535,"marketCap":255737426},{"date":"2025-03-07","current":-2.016076,"twenty":-18.870576,"median":-3.675256,"eighty":3.140711,"marketCap":270988849},{"date":"2025-03-14","current":-2.043071,"twenty":-18.770547,"median":-3.622752,"eighty":3.134262,"marketCap":274617311},{"date":"2025-03-21","current":-1.956404,"twenty":-18.702346,"median":-3.580076,"eighty":3.119455,"marketCap":262968037},{"date":"2025-03-28","current":-1.905256,"twenty":-18.667487,"median":-3.539183,"eighty":3.098279,"marketCap":256093056},{"date":"2025-04-04","current":-1.619681,"twenty":-18.629597,"median":-3.500917,"eighty":3.07965,"marketCap":217707743},{"date":"2025-04-11","current":-1.47192,"twenty":-18.550787,"median":-3.448348,"eighty":3.068826,"marketCap":197846686},{"date":"2025-04-17","current":-1.767441,"twenty":-18.550787,"median":-3.440869,"eighty":3.068826,"marketCap":237568801},{"date":"2025-04-25","current":-2.119792,"twenty":-18.512897,"median":-3.433421,"eighty":3.031937,"marketCap":284929783},{"date":"2025-05-02","current":-2.194414,"twenty":-18.505319,"median":-3.425258,"eighty":3.031809,"marketCap":287053462},{"date":"2025-05-09","current":-1.960343,"twenty":-18.42954,"median":-3.407827,"eighty":3.023761,"marketCap":256434426},{"date":"2025-05-16","current":-2.33193,"twenty":-18.384072,"median":-3.384332,"eighty":3.019868,"marketCap":305042146},{"date":"2025-05-23","current":-2.542594,"twenty":-18.323449,"median":-3.374901,"eighty":3.001956,"marketCap":332599278},{"date":"2025-05-30","current":-2.934663,"twenty":-18.317387,"median":-3.360234,"eighty":2.985717,"marketCap":383886163},{"date":"2025-06-06","current":-2.978551,"twenty":-18.297684,"median":-3.298464,"eighty":2.980935,"marketCap":389627233},{"date":"2025-06-13","current":-2.920033,"twenty":-18.238576,"median":-3.271041,"eighty":2.961744,"marketCap":381972474}],"updateTime":1750112034736}}}